Method Development and Validation for The Simultaneous Estimation of Pioglitazone and Glimepiride in Bulk and Pharmaceutical Dosage Forms by RP-HPLC

A simple, accurate and precise High Performance Liquid Chromatographic (HPLC) method was developed for the simultaneous estimation of Pioglitazone and Glimepiride in bulk and Pharmaceutical dosage form. Chromatogram was run through Inertsil – C18, ODS column, 150 x 4.6 mm, 5µ. Mobile phase containing Methanol:Acetonitrile taken in the ratio 70:30 was pumped through column at a flow rate of 1 ml/min. Optimized wavelength selected was 289 nm. Retention time of Pioglitazone and Glimepiride was found to be 4.713 min and 6.691 min. The % RSD for Pioglitazone and Glimepiride was 0.042 and 0.057. % Recovery was obtained as 100.16% and 100.29% for Pioglitazone and Glimepiride respectively. Obtained LOD, LOQ values of Pioglitazone and Glimepiride were 0.070, 0.212 and 0.096, 0.293µg/ml respectively. Linearity range was 20 – 80µg/ml for both the drugs. Regression equation of Pioglitazone was y=9884.3x-380.39 and that of Glimepiride is y=56481x-2387.5 Results show that the retention and run time were decreased, so it is evident that the method developed was simple and economical that can be adopted in regular Quality control test in Industries.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-03
DOI
https://doi.org/10.5281/zenodo.14269584
Primary Topic
Retinal Development and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Method Development and Validation for The Simultaneous Estimation of Pioglitazone and Glimepiride in Bulk and Pharmaceutical Dosage Forms by RP-HPLC

Zenodo (CERN European Organization for Nuclear Research)
Retinal Development and Disorders
article

Method Development and Validation for The Simultaneous Estimation of Pioglitazone and Glimepiride in Bulk and Pharmaceutical Dosage Forms by RP-HPLC

article en

Abstract

A simple, accurate and precise High Performance Liquid Chromatographic (HPLC) method was developed for the simultaneous estimation of Pioglitazone and Glimepiride in bulk and Pharmaceutical dosage form. Chromatogram was run through Inertsil – C18, ODS column, 150 x 4.6 mm, 5µ. Mobile phase containing Methanol:Acetonitrile taken in the ratio 70:30 was pumped through column at a flow rate of 1 ml/min. Optimized wavelength selected was 289 nm. Retention time of Pioglitazone and Glimepiride was found to be 4.713 min and 6.691 min. The % RSD for Pioglitazone and Glimepiride was 0.042 and 0.057. % Recovery was obtained as 100.16% and 100.29% for Pioglitazone and Glimepiride respectively. Obtained LOD, LOQ values of Pioglitazone and Glimepiride were 0.070, 0.212 and 0.096, 0.293µg/ml respectively. Linearity range was 20 – 80µg/ml for both the drugs. Regression equation of Pioglitazone was y=9884.3x-380.39 and that of Glimepiride is y=56481x-2387.5 Results show that the retention and run time were decreased, so it is evident that the method developed was simple and economical that can be adopted in regular Quality control test in Industries.

Zenodo (CERN European Organization for Nuclear Research)
Industry, innovation and infrastructure
Openalex Percentile: Top 62%
Retinal Development and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Method Development and Validation for The Simultaneous Estimation of Pioglitazone and Glimepiride in Bulk and Pharmaceutical Dosage Forms by RP-HPLC · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS